CSF3R Mutations Have a High Degree of Overlap with CEBPA Mutations in Pediatric AML

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2016 May 5

PMID 27143256

Citations 29

Authors

Julia E Maxson

Rhonda E Ries

Yi-Cheng Wang

Robert B Gerbing

E Anders Kolb

Sarah L Thompson

Jaime M Guidry Auvil

Marco A Marra

Yussanne Ma

Zusheng Zong

Andrew J Mungall

Richard Moore

William Long

Patee Gesuwan

Tanja M Davidsen

Leandro C Hermida

Seamus B Hughes

Jason E Farrar

Jerald P Radich

Malcolm A Smith

Daniela S Gerhard

Alan S Gamis

Todd A Alonzo

Soheil Meshinchi

Affiliations

Soon will be listed here.

Citing Articles

Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.

Maffei R, Paolini A, Conte B, Riva G, Nasillo V, Creti F Ann Hematol. 2025; 104(1):263-274.

PMID: 39907800 PMC: 11868254. DOI: 10.1007/s00277-025-06232-1.

Gene Expression of /CD114 Is Associated with Poorer Patient Survival in Glioma.

Bark S, Dalmolin M, Malafaia O, Roesler R, Fernandes M, Isolan G Int J Mol Sci. 2024; 25(5).

PMID: 38474265 PMC: 10931759. DOI: 10.3390/ijms25053020.

CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition.

Swoboda A, Arfelli V, Danese A, Windisch R, Kerbs P, Redondo Monte E Hemasphere. 2023; 7(10):e958.

PMID: 37841755 PMC: 10569757. DOI: 10.1097/HS9.0000000000000958.

RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development.

Carratt S, Kong G, Coblentz C, Schonrock Z, Maloney L, Weeder B Leukemia. 2023; 37(5):1141-1146.

PMID: 36894620 PMC: 10544281. DOI: 10.1038/s41375-023-01862-8.

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia.

Farrar J, Smith J, Othus M, Huang B, Wang Y, Ries R J Clin Oncol. 2023; 41(16):2949-2962.

PMID: 36795987 PMC: 10414715. DOI: 10.1200/JCO.22.01114.

References

Corey S, Burkhardt A, Bolen J, Geahlen R, Tkatch L, Tweardy D . Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci U S A. 1994; 91(11):4683-7. PMC: 43852. DOI: 10.1073/pnas.91.11.4683. View

Sano H, Ohki K, Park M, Shiba N, Hara Y, Sotomatsu M . CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21). Br J Haematol. 2015; 170(3):391-7. DOI: 10.1111/bjh.13439. View

Futami M, Zhu Q, Whichard Z, Xia L, Ke Y, Neel B . G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase. Blood. 2011; 118(4):1077-86. PMC: 3148159. DOI: 10.1182/blood-2009-12-261636. View

Lieschke G, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C . Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994; 84(6):1737-46. View

Beekman R, Valkhof M, van Strien P, Valk P, Touw I . Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia. Haematologica. 2013; 98(5):e62-3. PMC: 3640133. DOI: 10.3324/haematol.2013.085050. View

Gotlib J, Maxson J, George T, Tyner J . The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood. 2013; 122(10):1707-11. PMC: 3765056. DOI: 10.1182/blood-2013-05-500959. View

Corey S, Zuo S, Krohn E, Donnenberg A, Zorich P, Romero G . Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor. J Biol Chem. 1998; 273(6):3230-5. DOI: 10.1074/jbc.273.6.3230. View

Gombart A, Hofmann W, Kawano S, Takeuchi S, Krug U, Kwok S . Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood. 2002; 99(4):1332-40. DOI: 10.1182/blood.v99.4.1332. View

Ward A, van Aesch Y, Schelen A, Touw I . Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood. 1999; 93(2):447-58. View

10.

Pardanani A, Lasho T, Laborde R, Elliott M, Hanson C, Knudson R . CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013; 27(9):1870-3. PMC: 4100617. DOI: 10.1038/leu.2013.122. View

11.

Pabst T, Mueller B, Zhang P, Radomska H, Narravula S, Schnittger S . Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001; 27(3):263-70. DOI: 10.1038/85820. View

12.

Schuback H, Arceci R, Meshinchi S . Somatic characterization of pediatric acute myeloid leukemia using next-generation sequencing. Semin Hematol. 2013; 50(4):325-32. DOI: 10.1053/j.seminhematol.2013.09.003. View

13.

van de Geijn G, Gits J, Aarts L, Heijmans-Antonissen C, Touw I . G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood. 2004; 104(3):667-74. DOI: 10.1182/blood-2003-08-2913. View

14.

Tian S, Lamb P, Seidel H, Stein R, Rosen J . Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood. 1994; 84(6):1760-4. View

15.

Maxson J, Gotlib J, Pollyea D, Fleischman A, Agarwal A, Eide C . Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013; 368(19):1781-90. PMC: 3730275. DOI: 10.1056/NEJMoa1214514. View

16.

Maxson J, Luty S, MacManiman J, Abel M, Druker B, Tyner J . Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization. J Biol Chem. 2014; 289(9):5820-7. PMC: 3937653. DOI: 10.1074/jbc.M113.508440. View

17.

Zhu Q, Robinson L, Roginskaya V, Corey S . G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses. Blood. 2003; 103(9):3305-12. DOI: 10.1182/blood-2003-06-1861. View

18.

Dao K, Solti M, Maxson J, Winton E, Press R, Druker B . Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. Leuk Res Rep. 2014; 3(2):67-9. PMC: 4145163. DOI: 10.1016/j.lrr.2014.07.002. View

19.

Nicholson S, Oates A, Harpur A, Ziemiecki A, Wilks A, Layton J . Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc Natl Acad Sci U S A. 1994; 91(8):2985-8. PMC: 43499. DOI: 10.1073/pnas.91.8.2985. View

20.

Fleischman A, Maxson J, Luty S, Agarwal A, Royer L, Abel M . The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood. 2013; 122(22):3628-31. PMC: 3837511. DOI: 10.1182/blood-2013-06-509976. View